GLP-1 Medications Guide

Evidence-based information on GLP-1 receptor agonists for weight loss and metabolic health

An illustrative generic injection pen, blister strip and water glass
Illustrative AI-generated image; not an actual product or patient.

GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications that have reshaped weight loss and diabetes management. The category now includes three FDA-approved pills alongside the injectables, following the April 2026 approval of orforglipron. Our guides cover choosing between them, administration, clinical indications beyond weight, and managing side effects.

Latest approval

Orforglipron (Foundayo) — the first GLP-1 pill with no food or water restrictions

FDA approved Foundayo, the oral GLP-1 medicine orforglipron, on April 1, 2026. Product approval, suitability for an individual and an affordable prescription are separate questions.

New Practical Guides

Oral GLP-1 Medications

Beyond Weight Loss

Safety and Side Effects

Medication Comparisons

Semaglutide Resources

Tirzepatide Resources

Looking for a Provider?

Read our detailed reviews of top GLP-1 telehealth providers to find the best program for your needs.

Browse Provider Reviews